Balancing treatment allocations by clinician or center in randomized trials allows unacceptable levels of treatment prediction
- PMID: 21349013
- DOI: 10.1111/j.1756-5391.2009.01023.x
Balancing treatment allocations by clinician or center in randomized trials allows unacceptable levels of treatment prediction
Abstract
Objective: Randomized controlled trials are the standard method for comparing treatments because they avoid the selection bias that might arise if clinicians were free to choose which treatment a patient would receive. In practice, allocation of treatments in randomized controlled trials is often not wholly random with various 'pseudo-randomization' methods, such as minimization or balanced blocks, used to ensure good balance between treatments within potentially important prognostic or predictive subgroups. These methods avoid selection bias so long as full concealment of the next treatment allocation is maintained. There is concern, however, that pseudo-random methods may allow clinicians to predict future treatment allocations from previous allocation history, particularly if allocations are balanced by clinician or center. We investigate here to what extent treatment prediction is possible.
Methods: Using computer simulations of minimization and balanced block randomizations, the success rates of various prediction strategies were investigated for varying numbers of stratification variables, including the patient's clinician.
Results: Prediction rates for minimization and balanced block randomization typically exceed 60% when clinician is included as a stratification variable and, under certain circumstances, can exceed 80%. Increasing the number of clinicians and other stratification variables did not greatly reduce the prediction rates. Without clinician as a stratification variable, prediction rates are poor unless few clinicians participate.
Conclusion: Prediction rates are unacceptably high when allocations are balanced by clinician or by center. This could easily lead to selection bias that might suggest spurious, or mask real, treatment effects. Unless treatment is blinded, randomization should not be balanced by clinician (or by center), and clinician-center effects should be allowed for instead by retrospectively stratified analyses.
© 2009 Blackwell Publishing Asia Pty Ltd and Chinese Cochrane Center, West China Hospital of Sichuan University.
Similar articles
-
Studywise minimization: a treatment allocation method that improves balance among treatment groups and makes allocation unpredictable.J Clin Epidemiol. 2010 Oct;63(10):1118-22. doi: 10.1016/j.jclinepi.2009.11.014. Epub 2010 Mar 20. J Clin Epidemiol. 2010. PMID: 20304606
-
New algorithm for treatment allocation reduced selection bias and loss of power in small trials.J Clin Epidemiol. 2008 Feb;61(2):119-24. doi: 10.1016/j.jclinepi.2007.04.002. Epub 2007 Aug 23. J Clin Epidemiol. 2008. PMID: 18177784
-
Eliminating bias in randomized controlled trials: importance of allocation concealment and masking.Fam Med. 2007 Feb;39(2):132-7. Fam Med. 2007. PMID: 17273956
-
Randomization procedures in orthopaedic trials.Arthroscopy. 2008 Jul;24(7):834-8. doi: 10.1016/j.arthro.2008.01.011. Epub 2008 Mar 21. Arthroscopy. 2008. PMID: 18589273 Review.
-
Pseudo cluster randomization dealt with selection bias and contamination in clinical trials.J Clin Epidemiol. 2006 Apr;59(4):381-6. doi: 10.1016/j.jclinepi.2005.10.003. Epub 2006 Feb 14. J Clin Epidemiol. 2006. PMID: 16549260 Review.
Cited by
-
Run-Reversal Equilibrium for Clinical Trial Randomization.PLoS One. 2015 Jun 16;10(6):e0128812. doi: 10.1371/journal.pone.0128812. eCollection 2015. PLoS One. 2015. PMID: 26079608 Free PMC article.
-
Idraparinux or idrabiotaparinux for long-term venous thromboembolism treatment: a systematic review and meta-analysis of randomized controlled trials.PLoS One. 2013 Nov 20;8(11):e78972. doi: 10.1371/journal.pone.0078972. eCollection 2013. PLoS One. 2013. PMID: 24278113 Free PMC article.
-
Second asymptomatic carotid surgery trial (ACST-2): a randomised comparison of carotid artery stenting versus carotid endarterectomy.Lancet. 2021 Sep 18;398(10305):1065-1073. doi: 10.1016/S0140-6736(21)01910-3. Epub 2021 Aug 29. Lancet. 2021. PMID: 34469763 Free PMC article. Clinical Trial.
-
Pentasaccharides for the prevention of venous thromboembolism.Cochrane Database Syst Rev. 2016 Oct 31;10(10):CD005134. doi: 10.1002/14651858.CD005134.pub3. Cochrane Database Syst Rev. 2016. PMID: 27797404 Free PMC article.
-
Investigating the relationship between predictability and imbalance in minimisation: a simulation study.Trials. 2013 Mar 27;14:86. doi: 10.1186/1745-6215-14-86. Trials. 2013. PMID: 23537389 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources